fda approved glp-1 agonists GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Patient education tips for GLP-1,
Description
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
From Diabetes to Diverse Domains: The Multifaceted Roles of GLP-1 Receptor Agonists
2024;385:e078225
Hollingshead, B
Despite the pleiotropic benefits increasingly observed for existing novel AOMs, HCPs and patients should temper enthusiasm with potential long-term adverse effects, and costs to society and healthcare systems
However, they stand out for their motivations
